Untreated IPF Linked to 50% Mortality Rate at 3 Years

Untreated IPF Linked to 50% Mortality Rate at 3 Years

315513

Untreated IPF Linked to 50% Mortality Rate at 3 Years

If left untreated by anti-fibrotic medications, idiopathic pulmonary fibrosis (IPF) has a 50% mortality rate after three years, according to a recent observational study using real-world data. This is compared with a 26–31% mortality rate among IPF patients taking available anti-fibrotics, such as Esbriet (pirfenidone) and Ofev (nintedanib). Additionally, the study found that patients who don’t take such medications face a more than 40% rate of respiratory-related hospitalizations. Recommended Reading August 16, 2019 Health Insights…

You must be logged in to read/download the full post.